
Clear Gene is a biotechnology company that helps detect cancer that remains after treatment, known as residual disease. Using genomics and machine learning, the company focuses on improving detection for solid tumors such as breast cancer. Clear Gene’s software and test kits help clinical labs run more samples at lower cost using their existing equipment.

Investment Details
Funding Round
Seed
Milestones
Funded in 2025

About the Founder
Dr. Brandon Steelman
Dr. Brandon Steelman is the founder of Clear Gene, which he started in 2012 to develop RNA-based diagnostic tests. His work combines molecular biology and data science to improve clinical outcomes in areas such as cancer and infectious disease.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


